When you microdose, you naturally stretch your supply over a longer period
The trial results showed that after a 68-week treatment period, the oral semaglutide group achieved a significant weight reduction compared to the placebo group, with a 17.4% decrease in body weight versus 1.8% in the placebo group
Even at the highest dose of 2.4 mg, where the risk appears greatest, most patients tolerate the medication without developing this side effect
Research Use Disclaimer This product is intended strictly for laboratory research and analytical purposes only
This is a promising first step, and it could pave the way for Medicare to eventually cover these drugs as well
Methods: 25 women with PCOS and obesity, aged 33.7 5.3 years (mean SD), were treated with once-weekly subcutaneous semaglutide 1.0 mg as an adjunct to metformin 2000 mg/day and lifestyle intervention for 16 weeks